Fortaleza Asset Management’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-37,615
Closed -$265K 108
2018
Q1
$265K Hold
37,615
1.61% 10
2017
Q4
$244K Buy
37,615
+14,240
+61% +$90.6K 1.53% 17
2017
Q3
$145K Buy
23,375
+10,500
+82% +$53.5K 0.27% 113
2017
Q2
$55K Hold
12,875
0.1% 154
2017
Q1
$58K Sell
12,875
-12,000
-48% -$67.1K 0.12% 144
2016
Q4
$136K Sell
24,875
-20,025
-45% -$110K 0.29% 101
2016
Q3
$287K Buy
44,900
+25,275
+129% +$131K 0.4% 57
2016
Q2
$89K Buy
19,625
+4,715
+32% +$20.5K 0.07% 125
2016
Q1
$58.4K Hold
14,910
0.04% 134
2015
Q4
$83K Sell
14,910
-370
-2% -$2.52K 0.05% 138
2015
Q3
$96K Buy
+15,280
New +$102K 0.07% 132

Other funds holding CTSO

Fortaleza Asset Management's CTSO Position: Q2 2018 in Review

Fortaleza Asset Management sold out of Cytosorbents Corp (CTSO) in Q2 2018, closing a stake of 37,615 shares — an estimated $265K sold.

Fortaleza Asset Management first reported a position in CTSO in Q3 2015 and held it in 11 quarters. The position peaked at $287K in Q3 2016. 75 funds tracked by Wall St. Rank hold CTSO as of Q2 2018.

  • Fortaleza Asset Management reported no remaining Cytosorbents Corp position as of Q2 2018 after selling out during the quarter.
  • Fortaleza Asset Management sold 37,615 Cytosorbents Corp shares in Q2 2018, an estimated $265K.
  • Fortaleza Asset Management first reported a position in Cytosorbents Corp in Q3 2015 and held it in 11 quarters.
  • Fortaleza Asset Management's Cytosorbents Corp position peaked at $287K in Q3 2016.
  • 75 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2018.

Based on Fortaleza Asset Management's 13F filing for Q2 2018, filed 17 Jul 2018.